Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $6.10
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The […]
Shares of Applied Therapeutics, Inc. (NASDAQ:APLT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The […]
